Prot# SP-1011-003: Fluticasone propionate Oral Dispersible Tablet Formulation in Eosinophilic Esophagitis: A Two-Part, Randomized, Double-blind, Placebo-Controlled Study of APT-1011 in Adult Subjects with Eosinophilic Esophagitis

  • Hirano, Ikuo (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/27/20 → 5/27/23

Funding

  • Syneos Health, Inc. (Prot# SP-1011-003 // Prot# SP-1011-003)
  • Adare Pharmaceuticals, Inc. (Prot# SP-1011-003 // Prot# SP-1011-003)